Condensed Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (10,245,922)	$ (8,961,815)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation	678,613	622,064
Proceeds from issuance of common stock in exchange for services	6,250	12,500
Amortization of internally developed software	1,182,766	958,639
Depreciation of property and equipment	22,433	45,358
Bad debt expense	106,581	161,074
Amortization of debt issuance costs on term loan	77,384	4,605
Amortization of discount and debt issuance costs on convertible notes		1,088
Amortization of discount on bridge notes		869,600
Change in fair value of derivative liabilities		(1,311,700)
Loss on extinguishment on bridge notes		2,740,425
Loss on extinguishment of convertible notes		260,185
Gain on extinguishment on note payable		(788,156)
Change in operating assets and liabilities:
Accounts receivable - unbilled	(588,769)	(1,086,259)
Accounts receivable	1,297,946	(1,637,124)
Prepaid expenses and other current assets	26,601	90,894
Operating lease right-of-use asset	148,431
Tax credit receivable		38,503
Accounts payable	1,626,385	(959,754)
Accrued expenses	521,435	198,893
Accrued interest	(8,167)	(1,708,922)
Operating lease liability	(147,276)
Deferred revenue	(522,411)	(218,508)
Net cash used in operating activities	(5,817,720)	(10,668,410)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(215,504)	(2,550)
Capitalization of internally developed software	(2,975,686)	(1,035,367)
Net cash used in investing activities	(3,191,190)	(1,037,917)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of bridge notes payable		500,000
Proceeds from issuance of term loan		3,500,000
Proceeds from exercise of stock options	78,641	58,648
Proceeds from issuance of common stock in connection with initial public offering		18,000,000
Payment of offering costs in connection with the issuance of common stock in connection with initial public offering		(2,339,816)
Proceeds from issuance of common stock in connection with private placement		20,999,988
Payment of transaction costs in connection with the issuance of common stock in connection with private placement		(1,434,999)
Proceeds from exercise of warrants		992
Proceeds from issuance of over-allotment shares of common stock, net of transaction costs of $202,499		2,497,501
Payment of principal to bridge note holders		(3,000,000)
Payment of debt issuance costs in connection with note payable		(32,917)
Payment of term loan	(3,500,000)
Net cash (used in) provided by financing activities	(3,421,359)	38,749,397
Net change in cash	(12,430,269)	27,043,070
Cash at beginning of period	27,738,979	695,909
Cash at end of period	15,308,710	27,738,979
Supplemental disclosure of cash flow information:
Cash paid for interest	161,579	2,824,032
Supplemental disclosure of non-cash investing and financing activities:
Conversion of redeemable convertible preferred stock into common stock		11,173,076
Conversion of convertible notes and accrued interest into common stock		6,748,729
Conversion of bridge notes and accrued interest into common stock		4,717,646
Issuance of common stock warrants as offering costs in connection with public offering of common stock		374,400
Issuance of common stock warrants in connection with term loan		49,072
Issuance of common stock warrants in connection with private placement		$ 10,624,759
Non-cash amounts of lease liabilities arising from obtaining right-of use-assets	$ 333,123